JOHNSON & JOHNSON revenue for the last year amounted to 1.45 T MXN, the most of which — 930.09 B MXN — came from its highest performing source at the moment, Innovative Medicine, the year earlier bringing 1.03 T MXN. The greatest contribution to the revenue figure was made by United States — last year it brought JOHNSON & JOHNSON 788.86 B MXN, and the year before that — 947.53 B MXN.